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Abstract
Background: c-Secretase is an intramembrane aspartyl protease whose cleavage of the amyloid precursor protein (APP)
generates the amyloid b-peptide (Ab) and the APP intracellular domain. Ab is widely believed to have a causative role in
Alzheimer’s disease pathogenesis, and therefore modulation of c-secretase activity has become a therapeutic goal. Besides
APP, more than 50 substrates of c-secretase with different cellular functions during embryogenesis as well as adulthood
have been revealed. Prior to c-secretase cleavage, substrates are ectodomain shedded, producing membrane bound C-
terminal fragments (CTFs).
Principal Findings: Here, we investigated c-secretase cleavage of five substrates; APP, Notch1, N-cadherin, ephrinB and p75
neurotrophin receptor (p75-NTR) in membranes isolated from embryonic, young or old adult rat brain by analyzing the
release of the corresponding intracellular domains (ICDs) or Ab40 by western blot analysis and ELISA respectively. The
highest levels of all ICDs and Ab were produced by embryonic membranes. In adult rat brain only cleavage of APP and
Notch1 could be detected and the Ab40 and ICD production from these substrates was similar in young and old adult rat
brain. The CTF levels of Notch1, N-cadherin, ephrinB and p75-NTR were also clearly decreased in the adult brain compared
to embryonic brain, whereas the APP CTF levels were only slightly decreased.
Conclusions: In summary our data suggests that c-secretase dependent ICD production is down-regulated in the adult
brain compared to embryonic brain. In addition, the present approach may be useful for evaluating the specificity of c-
secretase inhibitors.
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Introduction
c-Secretase is an intramembrane aspartyl protease which plays
a pivotal role in Alzheimer’s disease since it mediates the release of
the amyloid b-peptide (Ab) from the amyloid precursor protein
(APP) [1]. Fibrils of polymerized Ab are deposited extracellularly
as senile plaques, one of the hallmarks of AD affected brains [2]. In
addition, the pre-fibrillar oligomeric Ab is believed to contribute to
the pathogenic mechanisms that lead to synaptic dysfunction and
neuronal loss in AD [3,4]. Prior to c-secretase cleavage, the
ectodomain of APP is shedded by b-secretase or a-secretase [5,6],
generating membrane bound C-terminal fragments (CTFs) which
are further processed by c-secretase. The sequential processing of
APP by b- and c-secretase results in Ab peptides of various lengths,
of which the 40 or 42 residue peptides are the most abundant [7].
The latter aggregates more easily and is the species implicated
early in plaque formation. In addition to the Ab-generating
cleavage site in the middle of the membrane, c-secretase cleaves
APP CTFs close to the membrane-cytoplasm boundary (e-site
cleavage), generating the APP intracellular domain (AICD) [8,9].
c-Secretase is composed of at least four subunits, presenilin (PS),
nicastrin, anterior pharynx defective-1 (Aph-1) and presenilin
enhancer-2 (Pen-2) [10,11], possibly in a 1:1:1:1 stoichiometry
[12]. PS is endoproteolytically cleaved into N- and C-terminal
fragments (PS-NTF and PS-CTF) [13] during maturation to an
active complex. There exist two homologues of PS, presenilin-1
(PS1) and presenilin-2 (PS2) and two homologues of Aph-1 in
humans, Aph-1a and Aph-1b [14]. In addition, there are two
splice variants of Aph-1a. PS1 and PS2 do not coexist in the same
c-secretase complex and neither do the different Aph-1 isoforms.
Thus, at least six distinct complexes with different subunit
composition might form [14–17].
PLoS ONE | www.plosone.org 1 March 2010 | Volume 5 | Issue 3 | e9772In addition to APP, c-secretase cleaves more than 50 other
substrates [18] in a similar manner, among which the Notch
receptor is the most characterized. Upon maturation, the Notch
receptor is cleaved by furin-like convertases, at the S1 site, forming
a heterodimer that is targeted to the plasma membrane. Activation
of Notch, by ligand binding, induces cleavage by ADAM
metalloproteases at the extracellular S2 site resulting in a
membrane-anchored truncated form of Notch, which is processed
by c-secretase (sites S3 and S4) [19]. The e-cleavage in APP
corresponds to the S3 cleavage of Notch which results in the
liberation of the Notch intracellular domain (NICD) which enters
the nucleus and regulates transcription [20–22]. The Notch
pathway controls a broad range of events during embryonic and
adult development such as cell fate decisions and proliferation
[23,24]. Notch1 deficiency is an embryonic-lethal phenotype
associated with severe developmental deficits, including disturbed
somitogenesis [25,26]. N-cadherin, ephrinB and p75 neurotrophin
receptor (p75-NTR) are three other important c-secretase
substrates [27–31]. N-cadherin is a cell adhesion molecule which
regulates synaptic contact, synaptogenesis, long-term potentiation
and morphology of the dendritic spines. Interaction of ephrinB
with ephrinB receptors is essential for the development of the
vascular system and the nervous system, and in the adult for the
regulation of synaptic plasticity. p75-NTR is involved in neuronal
death during development and following injury and also in
neuronal differentiation and axon elongation. In analogy with
NICD, it is possible that c-secretase released intracellular domains
(ICDs) from other substrates also play a role in signal
transduction/transcriptional activation [32]. For example it has
been reported that AICD can regulate the transcription of the
tumor suppressor p53 [33]. In addition, N-cadherin ICD has been
shown to bind and promote degradation of the transcription factor
CREB binding protein [29]. c-Secretase mediated intramembrane
proteolysis may also be involved in non-nuclear signaling functions
such as formation/disassembly of receptor complexes (p75-NTR)
or src activation (ephrinB) [27,30]. Another suggested role of c-
secretase is as the proteasome of the membrane, removing the
substrates transmembrane domains [34]. c-Secretase cleaves with
loose sequence specificity and no consensus sequence within the
substrates has been identified. The substrates are with few
exceptions type I transmembrane proteins that have undergone
ectodomain shedding. However, the subunit composition of c-
secretase can regulate activity, cleavage site and substrate
specificity. The PS1 and PS2 complexes show differences in Ab
production and sensitivity to certain c-secretase inhibitors [35] and
PS1 deficiency results in a more severe phenotype than PS2
deficiency [36–38]. Further, Aph-1a seems to be the major isoform
required for c-secretase activity during mouse embryonic devel-
opment [39] while Aph-1b is suggested to be involved in c-
secretase cleavage of neuregulin-1 [40]. Hence, different csecre-
tase complexes seem to have different properties and physiological
functions. Interestingly, c-secretase inhibitor binding density has
been shown to be higher in postnatal rat brains than in adult [41]
suggesting that c-secretase could be developmentally regulated as
well. Furthermore, c-secretase substrate selectivity could be
regulated spatially through the association of c-secretase and its
substrates in lipid rafts [42–44]. During development, c-secretase
has been suggested to reside in non-raft membranes together with
several substrates but being translocated to lipid rafts in adult brain
[42].
Since c-secretase executes the final step in the APP processing,
thereby generating the pathogenic Ab peptides, modulation of its
activity for therapeutic purposes is extensively investigated. The
multitude of substrates makes this task difficult due to the risk of
side effects. Therefore, relevant assays for studying the cleavage of
different c-secretase substrates are important. Most assays that
exist today are based on cell lines often over-expressing the
substrate. To our knowledge there are no extensive studies in brain
tissue on c-secretase cleavage of endogenous substrates other than
APP, and it is not known whether this cleavage is developmentally
regulated. Therefore, we have here studied the cleavage of five c-
secretase substrates important for neuronal function; APP,
Notch1, N-cadherin, ephrinB and p75-NTR. The substrate
cleavage was examined in membrane preparations from embry-
onic (E17), 2–3 month-old and 16–18 month-old rat brain. c-
Secretase cleavage of all of the examined substrates was detected
in embryonic rat brain while only processing of APP and Notch1
was detected in the adult brain and to a much lower extent.
Here we conclude that c-secretase dependent ICD production is
decreased in adult rat brain membranes compared to embryonic.
Results
c-Secretase cleavage of endogenous Notch1 in
membrane preparations from rat brain
To study the cleavage of c-secretase substrates other than APP,
we first optimized the buffer conditions for the activity assay. The
metal chelator EDTA has been shown to efficiently block the
degradation of AICD in vitro in membranes prepared from
HEK293 cells [45,46]. In addition, EDTA has been shown to
induce shedding of the Notch receptor (S2 cleavage) and thereby
signaling (S3 cleavage) in a ligand-mimicking manner in cell
systems [47,48]. Here, we examined the effect of EDTA on AICD
and NICD in rat brain membranes. Membrane fractions from
adult rat brains were isolated by sequential centrifugation steps.
Nuclei and non-homogenized cells were removed by centrifuga-
tion at 10006g and membranes were collected by centrifugation at
100,0006g. The membranes were incubated at 37uC for 16 h in
Hepes buffer in the absence or presence of 5 mM EDTA and the
production of NICD and AICD, as well as the substrate levels,
were estimated by western blot analysis. EDTA increased the
levels of both AICD and NICD (Figure 1A), but in sodium citrate
buffer at pH 6.4 (previously used for studying c-secretase activity
[29,46]) this effect was less pronounced (data not shown). Even in
the EDTA treated samples, NICD was barely detected, using an
antibody directed to the C-terminal of Notch1, C-20. However,
using a NICD specific antibody, Val1744, NICD was readily
detected. As previously reported, we noted that EDTA was
necessary for the S2 cleavage of Notch1 to occur (Figure 1A), and
5 mM EDTA was added in the subsequent activity experiments.
The EDTA induced production of the S2 cleaved Notch1
fragment was not inhibited by the c-secretase inhibitor
L-685,458 (Figure 2A).
We also wanted to investigate whether cleavage of Notch1 and
APP could be detected in a commonly used cell-line in the c-
secretase field, the BD3 cells, lacking PS1 at one allele and both
alleles of PS2. As a negative control, BD8 cells which lack both
PS1 and PS2 were included. Indeed, we could detect cleavage of
endogenous APP and Notch1 in BD3 but not in BD8 cells
(Figure 1B). This cleavage was c-secretase dependent since it was
inhibited by L-685,458 (data not shown). The level of S2 cleaved
Notch1 was similar in membranes from BD3 and BD8 cells.
However, the level of S1 cleaved Notch1 was lower in the BD8
cells compared to BD3 cells. This could possibly be explained by
disruption of a positive feedback-loop in which Notch signalling
upregulates Notch mRNA expression. Indeed, activation of the
Caenorhabditis elegans homologue to Notch, Lin-12, has previously
been shown to be important for maintaining Lin-12 mRNA
c-Secretase in Rat Brain
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the S2 fragment (S2/S1) is increased since the c-secretase
dependent processing of this fragment is abolished in these cells.
Generation of ICDs from endogenous c-secretase
substrates in embryonic and adult rat brain membranes
Next, we studied c-secretase cleavage of different endogenous
substrates at different stages of development. We chose five different
neuronal substrates with important functions in the developing and
adult nervous system and studied the cleavage of these in membrane
preparations from E17 and 3 month-old rats. The membranes were
incubated at 37uC for 16 h in the absence or presence of the c-
secretase inhibitor L-685,458. The production of ICDs from APP,
Notch1, N-cadherin, ephrinB and p75-NTR was examined using
western blot analysis. Interestingly, we could detect cleavage of N-
cadherin, ephrinB and p75-NTR in the embryonic rat brain
membranes but not in the adult rat brain (Figure 2A). However,
substrate (CTF) levels per mg of protein were also higher in the
embryonic membrane preparation compared to adult. APP and
Notch1 processing was observed in both embryonic and adult rat
brain membranes but to a higher extent in the embryonic rat brain
membranes. The substrate levels of Notch1 (S1 and S2 cleaved) were
also higher in embryonic rat brain membranes (Figure 2A). For APP,
there was an approximately three-fold decrease between embryo and
adult AICD production although there was only a 20% decrease in
CTF levels (Figure 2B). Ponceau S staining confirmed that the total
amount of protein loaded onto the gel was similar in embryonic and
adult membrane preparations (Figure 2A, lower panel). To estimate
the c-secretase activity, independent of substrate levels, we added an
exogenous APP substrate, C99-FLAG, to the reaction. The
production of AICD-FLAG was detected by western blot and was
found to be higher in embryonic rat brain than in adult, which
indicates that the total c-secretase activity is higher in embryonic rat
brain (Figure 2C). Thus, for several substrates, the decreased
production of ICDs in adult brain membranes is probably mainly
due to lower substrate levels but for APP this is not the full
explanation.
The generation of all of the different ICDs was inhibited by L-
685,458, showing that the processing is indeed c-secretase
dependent. There was no significant difference in NICD levels
between the samples incubated at 37uC and NRC (Figure 2A),
indicating that there was no degradation of NICD during
incubation. Furthermore, when L685,458 was added to the
reaction after 16 h and the sample were incubated for an
additional 16 h, there was no change in the AICD levels during
the latter period in either the embryonic or in the adult rat brain
membranes. The addition of 10 mM of the protease inhibitors
antipain, bestatin and leupeptin and 5 mM EGTA to buffer H
(containing Complete
TM protease inhibitor cocktail from Roche
and 5 mM EDTA) did not alter the levels of AICD in the adult
brain. In addition, the ICDs of N-cadherin, p75-NTR and
ephrinB were still not detectable (data not shown). These results
suggest that the decreased ICD levels in the adult were not due to
increased ICD degradation.
Ab40 production in embryonic and adult rat brain
membranes
Since there was a marked difference in the production of AICD
between embryonic and adult rat brain we continued by
examining whether the production of Ab also differed. Mem-
branes from embryonic and adult rat brain were incubated for
16 h at 37uC in the absence or presence of L-685,458 and the
samples were analyzed by sandwich ELISA. Unfortunately we
could only quantify the Ab40 and not the Ab42 levels in this
system. In order to measure the starting levels of Ab40, RIPA
buffer was immediately added to NRC samples which were kept at
4uC prior to analysis. Contrary to AICD and NICD, we noticed a
decrease in Ab levels in samples incubated with L685,458 at 37uC
for 16 h compared to NRC, indicating some degradation of Ab40
during incubation. This was also the case for added synthetic Ab1-
40 (data not shown). Since neprilysin and insulin degrading
enzyme (IDE) are two major Ab degrading enzymes [50,51], we
added inhibitors to these proteases (thiorphan and 1,10-phenan-
throline respectively) to the samples to prevent degradation. We
also decreased the incubation period to 8 h. In this case there was
no significant degradation of Ab (Figure 2D, left panel, +
L685,458 compared to NRC). Using these conditions we
compared the Ab40 production in embryonic and adult rat brain
membranes and found it to be four to five times higher in
embryonic rat brain membranes compared to adult (Figure 2D).
Levels of c-secretase components and active c-secretase
in embryonic and adult rat brain
To investigate whether the decreased c-secretase activity could
be due to lower levels of c-secretase, we compared the levels of c-
secretase components in membranes prepared from embryonic
and adult rat brain. Most of the c-secretase components were
present to a higher degree in embryonic rat brain membranes
Figure 1. c-Secretase cleavage of endogenous Notch1 and APP
in adult rat brain or BD3 cells. (A) Adult rat brains (3 month-old)
were homogenized and membranes were isolated by sequential
centrifugations at 10006g and 100 0006g. Membranes were incubated
for 16 h at 37uC with or without 5 mM EDTA. The samples were
subjected to SDS-PAGE and western blotting using the antibodies
Notch1 C-20, directed to the C-terminal of Notch1, Val1744, only
recognizing the free N-terminal of NICD, or C1/6.1, directed to the
C-terminal of APP. (B) BD3 and BD8 cells were harvested in PBS and
membranes were prepared and incubated in buffer H containing 5 mM
EDTA for 16 h at 37uC. The samples were analyzed as described above.
doi:10.1371/journal.pone.0009772.g001
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higher in the adult rat brain membranes. Further, we investigated
whether the c-secretase components were degraded during the
incubation in the activity assay but we found no significant
difference in component levels between samples incubated at 37uC
for 16 h and non-incubated samples (data not shown).
Figure 2. Comparison of c-secretase dependent ICD and Ab40 production in embryonic and adult rat brain. (A) Membranes were
prepared from embryonic (day 17) and adult rat brains (3 month-old) and equal amounts of protein from the two preparations were incubated at 4uC
or at 37uC in the absence or presence of the c-secretase inhibitor L-685,458. The samples were separated by SDS-PAGE and analyzed by western blot
for ICDs from APP, Notch1, N-cadherin, ephrinB and p75-NTR. The different ICDs as well as CTFs were detected by C-terminal antibodies for the
different substrates. NICD was detected also by an antibody, Val1744, only recognizing the neoepitope generated following cleavage at the S3 site.
The embryonic and adult lanes are in all cases from the same western blot. To confirm that the amount of protein loaded onto the gel and transferred
to membrane was similar in embryonic (E) and adult (A) membrane preparations Ponceau S staining was used (lower panel). (B) Quantification of
AICD production and APP CTFs in embryonic and adult rat brain membranes. The AICD levels in the samples incubated at 37uC (left panel) and the
APP CTF levels in the non-incubated sample (4uC) were quantified using two standard points of synthetic AICD peptide. Data are presented as mean
values 6 SD (n=4). *, p,0.05 adult vs embryo. (C) Embryonic (E) and adult (A) rat brain membranes were assayed for c-secretase activity as above in
the presence or absence of C99-FLAG. Generation of endogenous AICD and AICD-FLAG was detected by the antibody C1/6.1, directed to the C-
terminal of APP. (D) The Ab40 levels were measured by sandwich ELISA in embryonic and adult rat brain membrane preparations containing equal
amounts of protein. The membranes were incubated for 8 h at 37uC in the absence or presence of the c-secretase inhibitor L-685,458. The no
reaction control (NRC) samples were excluded from incubation and instead treated directly with RIPA buffer to inhibit further production of Ab.
Production (right panel) was determined by subtracting Ab40 values obtained in the inhibited samples (+ L-685,458) from samples without inhibitor
(2 L-685,458). Data are presented as mean value 6 SD (n=4). *, p,0.05 adult vs embryo; #,p ,0.05+ L-685,458 vs2L-685,458 within the same age
group.
doi:10.1371/journal.pone.0009772.g002
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components reflected their incorporation into active c-secretase
complexes. For this purpose we used affinity capture where the
membranes from embryonic and adult rat brain were incubated in
the presence of a c-secretase inhibitor with a cleavable biotin
group (GCB) followed by incubation with streptavidin beads to
capture the c-secretase complexes. GCB is based on L685,458,
which efficiently inhibits processing of all the substrates tested
(Fig. 2A). In addition, GCB itself efficiently blocked Ab production
with a similar IC50 as L685,458 [52]. Thus, GCB is efficient in
capturing active c-secretase complexes. As a negative control L-
685,458 was added prior to the biotinylated inhibitor. The bound
c-secretase was eluted from the beads and analyzed by SDS-
PAGE and western blotting. Indeed, the higher levels of c-
secretase components found in embryonic rat brain also correlated
with higher levels of captured active c-secretase complex and the
differences were even more pronounced in this case (Figure 3C).
The levels of captured PS2-CTF were similar in embryonic and
adult rat brain (Figure 3C).
c-Secretase cleavage of Notch1 and APP in 2–3 month-
old and 16–18 month-old rat brain membranes
To further investigate the effect of age on c-secretase cleavage of
the different substrates we compared c-secretase activity in 2–3
and 16–18 month-old rat brain. In this comparison we used frozen
brains purchased from Rockland Immunochemicals Inc. Mem-
branes were prepared and the activity assay was performed as
described above. The generation of AICD, NICD and Ab40, as
well as the levels of APP CTFs and S2 cleaved Notch1, were
similar in 2–3 month-old and 16–18 month-old rat brains
(Figure 4A and B). The same conditions were used for the
young-old comparison as for the embryo-adult comparison. The
total c-secretase activity, assessed by the addition of C99-FLAG,
was also similar between the age groups (data not shown).
Furthermore, the c-secretase component levels did not differ
substantially between the two age groups (Figure 4C). No ICD
production from ephrinB, N-cadherin or p75-NTR was observed
in membranes from 2–3 month-old or 16–18 month-old rats (data
not shown).
Discussion
c-Secretase is responsible for intramembrane cleavage of various
type I transmembrane proteins following shedding of their
ectodomains. The functional diversity of the substrates, including
cell fate determination, cell-cell adhesion, neuritogenesis and synapse
formation, emphasizes the importance of c-secretase during
development as well as in adult life. Previously, c-secretase cleavage
has mostly been studied in cell lines where in many cases the
substrates have been over-expressed. In this report we demonstrate
c-secretase cleavage of five substrates; APP, Notch1, N-cadherin,
ephrinB and p75-NTR, in embryonic rat brain membranes but only
cleavage of APP and Notch1 in adult rat brain membranes. The c-
secretase processing of the substrates was monitored by comparing
the levels of formed ICDs from the different substrates using western
blot analysis. The finding that NICD production can be observed
from endogenously expressed Notch1 in rat brain membranes could
be useful for developing relevant screening assays for selective c-
secretase inhibitors/modulators. We also examined NICD produc-
tion in BD3 (PS1
+/2;P S 2
2/2)a n dB D 8c e l l s( P S 1
2/2;P S 2
2/2)
without overexpression of Notch. No NICD was produced in BD8
cells but by introducing one allele of PS1 as in the BD3 cells NICD
production was observed. Thus, the influence of wild type, mutated
or truncated PS1 or PS2 on substrate specificity (APP versus Notch
processing), could be examined by introducing these PS variants in
BD8 cells.
Figure 3. Levels of c-secretase components and active
complexes in embryonic and adult rat brain. (A) The levels of c-
secretase components in equal amounts of protein from embryonic (E)
and adult (A) membrane preparations were analyzed by western blot
using antibodies directed to the c-secretase complex components. (B)
Quantification of c-secretase components in embryonic and adult
membrane preparations from western blot. Equal amounts of protein
from four different embryonic and adult membrane preparations were
loaded together with three different dilutions of one of the membrane
samples. The intensities from the diluted samples were plotted as a
standard curve to which the other membrane preparations were
correlated. Data are presented as mean values 6 SD (n=4). *, p,0.05
adult vs embryo (C) Active c-secretase was captured from embryonic
and adult rat brain membranes with 200 nM of a biotinylated c-
secretase inhibitor in the presence or absence of 10 mM L-685,458
followed by the addition of streptavidin beads. Bound complexes and
10% of the input (IN) were separated on SDS-PAGE and detected by
western blot using antibodies directed to the c-secretase components.
doi:10.1371/journal.pone.0009772.g003
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Notch1, N-cadherin, ephrinB, and p75-NTR in membranes
prepared from embryonic and adult rat brain and found that
cleavage of all of these substrates, i.e. ICD production, was higher
in embryonic brain. The production of Ab from APP was also
higher in embryonic brain. For Notch1, the high level of
processing in the embryonic brain is in line with the critical role
of NICD in cell fate determination during embryogenesis. The
other substrates also have important functions during development
but it is not fully known to which extent these functions are c-
secretase dependent. The higher ICD production in embryonic rat
brain membranes could for Notch1, N-cadherin, ephrinB and
p75-NTR be explained by the higher CTF levels of the different
substrates. For APP, however, this is not the case since APP CTFs
were only slightly altered between embryonic and adult brain.
This is in accordance with our previous studies showing that APP
CTFs are present even after long incubation times and that c-
secretase appears to be the rate-limiting step in endogenous APP
processing [53]. One explanation for the reduced APP cleavage in
adult brain despite the presence of the substrate could be that c-
secretase and APP are spatially separated in the membranes.
Indeed, we have earlier demonstrated that whereas c-secretase is
located to lipid rafts in adult rat brain membranes, full length APP
and APP CTFs are located outside the rafts [43]. This is in
contrast to Vetrivel et al. who showed that the APP CTFs were
localized in lipid rafts [42]. The discrepancy could be due to the
different detergents used for lipid raft preparation in the two
studies. The c-secretase processing of an exogenous APP based
substrate, C99-FLAG was also decreased in the adult brain
membranes showing that substrate concentration per se is not a
limiting factor. The higher c-secretase activity in membranes from
embryonic rat brain is in line with the reported higher levels of
transition state c-secretase inhibitor binding in postnatal rat brain
compared to adult [41]. The finding that, of the substrates
examined, only c-secretase cleavage of APP and Notch1 was
detected in the adult is also in line with the side-effects observed
following c-secretase inhibitor administration. These side-effects,
including gastrointestinal toxicity and interference with B- and T-
lymphocyte maturation, seem mainly to be due to inhibition of
Notch processing and signaling [54–56].
Ab has been shown to be degraded by several proteases [57],
including IDE [50] and neprilysin [51]. Apart from Ab, IDE has
also been shown to degrade AICD [46]. To rule out the possibility
that the decreased ICD and Ab levels in adult brain membranes
Figure 4. NICD, AICD and Ab40 production and c-secretase components in 2–3 and 16–18 month-old rat brains. (A) Membranes were
isolated from 2–3 (young) and 16–18 month-old (old) rat brains, incubated for 16 h at 4uCo ra t3 7 uC in the absence or presence of the c-secretase
inhibitor, L-685,458, and subjected to SDS-PAGE and western blot analysis. NICD and AICD production was detected using the antibodies, Val1744
and C1/6.1 respectively. The Notch1 CTFs (S1 and S2 cleaved) were detected by the antibody Notch1 C-20. (B) Equal amounts of protein from
membranes from 2–3 and 16–18 month-old rat brain were subjected to western blot analysis of the c-secretase components nicastrin, PS1, PS2 and
Pen-2. (C) Membrane preparations were either incubated for 8 h at 37uC with or without the c-secretase inhibitor L-685,458 or directly treated with
RIPA buffer (NRC, no reaction control). Levels of Ab40 were measured by sandwich ELISA. Production (right panel) was determined by subtracting
Ab40 values obtained in the inhibited samples (+ L-685,458) from samples without inhibitor (2 L-685,458). Data are presented as mean value 6 SD
(n=4). #,p ,0.05+ L-685,458 vs2L-685,458 within the same age group.
doi:10.1371/journal.pone.0009772.g004
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decreased production we compared the level of produced AICD
after 16 h with that in samples further incubated in the presence of
c-secretase inhibitor for 16 h. No degradation of AICD was
observed in either embryonic or adult membrane preparations. For
NICD, we did not find any differences between samples that were
incubated at 37uC in the presence of a c-secretase inhibitor and the
samples that were not incubated at all, indicating that degradation
in this case is limited. For Ab, on the other hand,we had to decrease
the incubation time from 16 to 8 h and add the neprilysin inhibitor
thiorphan and the metalloprotease inhibitor 1,10-phenanthroline to
abolish the degradation. These precautions increased the Ab levels
in the embryonic brain more than in the adult brain (data not
shown), indicating that the degradation was higher in embryonic
brain. Therefore, the decreased levels in the adult were not due to
degradation. We also investigated whether the c-secretase compo-
nents were degraded, by comparing samples incubated at 4uCa n d
37uC, and found this not to be the case. Thus, the lack of
degradation makes our in vitro system suitable for studying c-
secretase dependent production of different ICDs and Ab.
However, in vivo the situation is more complex, and the levels of
the ICDsand Ab inthe braincould be affected by proteases that are
not present in our assay where the cytoplasm has been removed.
One explanation for the decreased c-secretase activity in adult
could be that the levels of the c-secretase components aredecreased.
Indeed, we found decreased levels of all c-secretase components
except PS2-CTF in the adult brain. Interestingly, the levels of PS2
were increased. This might be of importance since an increase in
PS2 containing c-secretase complexes have recently been associated
both in vitro and in vivo with an increased Ab42:Ab40 ratio [58]. The
decreased levels of the other components were even more
pronounced when we compared the amount of components
incorporated into an active complex, as determined by the ability
of a biotinylated c-secretase inhibitor to capture the components. In
general, the proportion of the components that were captured by
this inhibitor was lower in adult brain membranes and the slight
increase in PS2-CTF levels in adult brain was not reflected in
increased amount of PS2-CTF in active complexes. One explana-
tion for this could be that c-secretase in lipid rafts may be less
accessible to GCB and that c-secretase localizes to lipid rafts in a
higher proportion in adult than in embryonic brain [42].
Since age is a risk factor for Alzheimer’s disease we also
investigated whether c-secretase activity as well as component levels
changed with increased age of the adult rat. However, we found no
differences in c-secretase dependent production of AICD, NICD
and Ab40 and levels of c-secretase components between young (2–3
month-old) and old (16–18 month-old) adult rat brain membranes.
Again,we found no differences between non-incubated samplesand
samplesincubated at 37uC inthe presenceof a c-secretase inhibitor,
indicating that there is no degradation of NICD or Ab in our
system. We cannot exclude the possibility that the production of
Ab42, which were below the levels of quantification, could be
different between young and old rat brain.
Contrary to our study, Placanica et al. recently found decreased
Notch processing and lower levels of c-secretase components in
aged mice [59]. The difference in Notch processing might be
explained by the fact that they used a recombinant substrate
whereas we studied the processing of endogenous Notch. In
addition, we used 3 month-old rats as ‘‘young’’ animals, whereas
they used 1 month-old mice and it is possible that the high c-
secretase activity and component levels that we detect in the
embryonic rat brain to some extent remain at 1 month of age.
Furthermore, the difference in species could also give different
results. Placanica et al. also found a gender specific alteration in Ab
production at 24 months of age. In our young-old comparison we
used a mixed population of male and female brains and we can
therefore not compare our results with this study.
In conclusion we have demonstrated c-secretase cleavage of five
different substrates, APP, Notch1, N-cadherin, ephrinB and p75-
NTR in embryonic rat brain membranes. The c-secretase
dependent ICD production was dramatically down-regulated in
the adult and only cleavage of APP and Notch1 was detected. The
ability to study c-secretase cleavage of endogenous substrates in
brain tissue provides an additional approach in which the effect
and specificity of c-secretase inhibitors and modulators could be
examined.
Materials and Methods
Ethics Statement
All animals were handled in strict accordance with good animal
practice as defined by the relevant national and local animal
welfare guidelines, and all animal work was approved by the
Animal Trial Committee of Southern Stockholm (S80-08, S63-07).
c-Secretase inhibitor, C99-FLAG and APP CTF-50
The c-secretase inhibitor L-685,458 (Bachem) were dissolved in
DMSO and added to the reactions (final concentration of 1 mMo r
10 mM). The FLAG-tagged APP-based substrate C99-FLAG was
treated with 70% formic acid in order to dissociate possible
aggregates into monomers, dried in a vacuum centrifuge and
resuspended in the sample (20 ng/sample). The APP CTF-50
(AICD) peptide (Calbiochem) was dissolved in MilliQ water to a
concentration of 1 mg/ml and stored at 220uC until use when the
peptide was further diluted in MilliQ water before subjection to
SDS-PAGE.
Antibodies
The following antibodies were used for immunoblotting:
nicastrin, (MAB5556, Chemicon) raised against the final 18 C-
terminal residues; PS1-CTF (MAB5232, Chemicon) recognizing
the C-terminal loop region of PS1; PS1-NTF, (Calbiochem) raised
against amino acids 1–65 of human PS1; UD1, raised against
residues 1–11 of Pen-2 (a gift from Dr. Jan Na ¨slund, Karolinska
Institutet, Sweden); Aph-1aL (BioSite), raised against the C-
terminal residues 245–265 of human Aph-1aL; C1/6.1, raised
against the C-terminus of APP (a gift from Dr. Paul M. Mathews,
Nathan Kline Institute, NY, USA); Ephrin-B1 (C-18, Santa Cruz
Biotechnology) raised against the C-terminus of human ephrin-B1
but cross-reacts with ephrin-B2; N-Cadherin, (BD Biosciences)
raised against residues 802–819 of mouse N-Cadherin; p75-NTR
(Upstate) raised against residues 274–425 of rat p75-NTR;
Cleaved Notch1 (Val 1744, Cell Signaling) recognizing the
intracellular C-terminal domain of Notch1 only when cleaved
between Gly1743 and Val1744 (c-secretase cleavage); Notch1 (C-
20, Santa Cruz Biotechnology) raised against the C-terminus of
Notch1.
Preparation of membrane fractions from rat brain
Male (3 month-old) and pregnant female Sprague-Dawley rats
were obtained from B&K Universal (Sollentuna, Sweden) or
Taconic (Hudson, NY). The rats were sacrificed by carbon dioxide
and decapitated. For the young vs old comparison, rat brains from
2–3 month-old (young adults) and 16–18 month-old (old adults)
Sprague-Dawley rats were obtained from Rockland Immuno-
chemicals Inc. (Gilbertsville, PA). The rat brains were homoge-
nized by 25 strokes at 1500 rpm using a mechanical pestle-
homogenizer (IKALaborteknik RW20) in buffer containing
c-Secretase in Rat Brain
PLoS ONE | www.plosone.org 7 March 2010 | Volume 5 | Issue 3 | e977210 mM KCl and 10 mM Mops, pH 7.0 [29] supplemented with
Complete
TM protease inhibitor cocktail (PI) (Roche, Basel,
Switzerland). The brain homogenates were centrifuged at
10006g for 10 min and the post-nuclear supernatant was
centrifuged at 100 0006g for 1 h. The membrane fractions were
resuspended in 10 mM KCl and 10 mM Mops, pH 7.0,
supplemented with 20% glycerol, aliquoted and flash-frozen in
liquid N2. All centrifugation steps were carried out at 4uC.
Cell lines and membrane preparation
Blastocyst-derived embryonic stem cells lacking PS1 and PS2
(BD8 cells) or one allele of PS1 and both alleles of PS2 (BD3 cells)
[60] were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum, 1 mM
sodium pyruvate, 0.1 mM b-mercaptoethanol and non-essential
amino acids (Invitrogen). Cells were washed, harvested in PBS and
collected by centrifugation. Subsequently, cells were subjected to
membrane preparation as described above for rat brain.
c-Secretase activity assay
The membrane fractions were resuspended in buffer H (20 mM
Hepes pH 7.0, 150 mM NaCl, 5 mM EDTA and PI). The protein
concentration was measured by BCA protein assay kit (Pierce) and
was kept at 3–4 mg/ml when examining ICD production and
1.25 mg/ml for Ab40 measurements. The samples were incubated
in the absence or presence of the c-secretase inhibitor L-685,458
at 37uC for 8 or 16 h. In the cases where C99-FLAG was added,
the incubations were performed in buffer H containing 0.4%
CHAPSO. After incubation the samples were, in the case needed,
concentrated using a vacuum centrifuge and analyzed by SDS-
PAGE for the different ICDs.
SDS-PAGE and western blotting
Equal amounts of protein (40–120 mg for ICD detection and
15–30 mg for detection of c-secretase components) were mixed
with 26 Laemmli sample buffer and either heated at 95uC for
5 min (for ICD production) or kept at room temperature for
20 min (for c-secretase components) and subsequently separated
by SDS-PAGE on 4–12% Bis-Tris or 16% Tricine gels. Proteins
were transferred to nitrocellulose or PVDF membranes and
probed with primary antibodies. Horseradish peroxidase-coupled
secondary antibodies (Amersham) and ECL detection (Pierce and
Millipore) were used for visualization. To verify that the amount of
protein loaded onto the gel and transferred to membrane was
similar in embryonic and adult membrane preparations Ponceau S
staining was used. For quantification of c-secretase components,
the same membrane fraction at three different dilutions was
loaded on the same gel as four different embryonic and four
different adult membrane fractions. The intensity of all the bands
was measured and the diluted membrane fractions were used to
create a standard curve that was used for quantification of the
samples. For quantification of AICD and APP CTFs, 125 pg,
250 pg and 500 pg of synthetic AICD peptide (APP-CTF 50,
Calbiochem) were loaded on the same gel as activity assay samples
from four different embryonic and four different adult membrane
fractions. The AICD and the APP CTFs bands were quantified
using the two standard points bracketing the intensity of the
sample (two-point calibration). All quantifications were performed
using a CCD-camera (Fuji LAS-3000).
ELISA
De novo generation of Ab40 was analyzed by commercial
sandwich ELISA (Wako chemicals, Osaka, Japan) according to the
manufacturer’s instructions. The membrane fractions were incu-
bated in buffer H and PI, with or without 5 mM 1,10-
phenanthroline and 10 mM thiorphan for 8 or 16 h at 37uCa n d
the reaction was stopped by adding RIPA buffer (150 mM NaCl,
1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris-
HCl, pH 8.0) and boiling for 5 min. Control samples (NRC = no
reaction control) were not incubated. The samples were centri-
fuged at 10 0006g for 5 min at room temperature and the
supernatants were dispensed into the wells (100 mg protein/well)
coated with BNT77 antibody directed against amino acids 11–28
of Ab and incubated at 4uC overnight. The bound Ab40 was
detected by TMB reaction using HRP-conjugated BA27 antibody
directed against the C-terminus of Ab. All the measurements were
performed in duplicates or triplicates and Ab40 levels were
calculated from the rodent synthetic Ab(1–40) standard curve.
Affinity capture of the c-secretase complex
Membranes prepared from embryonic and adult rat brain were
resuspended in buffer H containing 0.5% CHAPSO and PI.
Magnetic streptavidin beads (Invitrogen) were added and the
samples were incubated overnight at 4uC to remove biotinylated
proteins. The samples were incubated with 200 nM of an affinity
probe based on L-685,458 coupled to biotin by a cleavable linker
(GCB) [52] for 20 min at 37uC with gentle shaking. As a negative
control10 mM L-685,458wasadded tothe sampleandincubatedat
10 min at 37uC prior to incubation with GCB. Magnetic
streptavidin beads were added and the samples were incubated
during2 h at4uC.Thebeads werewashed with buffer H containing
0.5% CHAPSO and bound proteins were eluted in Laemmli
sample buffer at 37uC for 45 min and subjected to SDS-PAGE.
Statistical analysis
The absolute values for Ab40 and Ab40 production in
membrane preparations from embryo and adult rats, and adult
and old rats, respectively, was analyzed using two-tailed student’s
t-test. A threshold value of 0.05 was chosen for significance in all
statistical analyses.
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